Why did doctors once recommend cigarettes?

Picture a cigarette advertisement from the middle of the last century and there is a decent chance a doctor is in it. White coat, steady gaze, a Camel between two fingers, quietly assuring you that the smart, medical choice is also the pleasant one. It looks absurd now. At the time it looked like reassurance. And when that reassurance stopped working, when actual science arrived and pointed the other way, the tobacco industry did something far more clever and far more lasting than lie. It went into the business of selling doubt.

01 · The pitchThe man in the white coat

For roughly two decades, from the 1930s into the 1950s, American cigarette brands borrowed the most trusted figure they could find: the physician. Ads showed doctors mid-examination, quoted their supposed brand preferences, and reassured readers that a given cigarette was easy on the throat. This was not a considered medical position. It was a marketing device, and a shrewd one, because a doctor’s endorsement does a specific job: it converts a worry into a permission. If the profession that worries about your health smokes this brand, the reasoning goes, how bad can it be? It helped, too, that smoking was genuinely everywhere in this era, doctors included, so a physician with a cigarette looked ordinary, not scandalous.

02 · The surveyMore doctors smoke Camels (allegedly)

The most famous example is R.J. Reynolds’ campaign for Camel, which ran as the brand’s mainstay from about 1946 to 1952 under the slogan “More Doctors Smoke Camels Than Any Other Cigarette.” It even appeared inside medical journals. The line rested on an impressive-sounding figure: a survey of 113,597 physicians. The number is real. The method behind it is the interesting part. The polling, run through Reynolds’ advertising agency, frequently worked like this: a representative would hand a doctor a free carton of Camels, and then, with the gift still warm, ask which brand he smoked. A great many named the one they had just been given. The methodology was never properly published, which is its own kind of tell.

03 · The evidence turns1950, and the numbers stop being friendly

Then the science caught up, and it did so on two continents at once. In 1950, in the United States, Ernst Wynder and Evarts Graham published a study in the Journal of the American Medical Association. The same year in Britain, Richard Doll and Austin Bradford Hill published in the British Medical Journal, comparing lung-cancer patients with matched controls and finding that heavy smokers were on the order of 25 times more likely to develop the disease. A case-control study can be argued with, so Doll and Hill went further. In 1951 they began following a large group of British doctors forward in time, watching who smoked and who fell ill. When those prospective results came in around 1954, pointing the same way, the link became very difficult to wave off. The friendly face in the advertisements now had a serious problem.

04 · The PlazaA meeting, and a decision

In December 1953, the heads of the major tobacco companies gathered at the Plaza Hotel in New York. They brought in John W. Hill, of the public relations firm Hill & Knowlton, and the question on the table was blunt: what do you do when the science is turning against your product? Hill’s answer was not to fight the evidence head-on. It was to fund research, project openness, and let the resulting appearance of ongoing inquiry keep the matter looking unresolved. Out of that meeting came the Tobacco Industry Research Committee, and, on 4 January 1954, a full-page advertisement in hundreds of American newspapers titled “A Frank Statement to Cigarette Smokers.” It reached tens of millions of readers, promised the industry took their health seriously, and pledged independent research into the question. It was, read one way, a model of corporate responsibility. Read another way, it was the opening move of a very long game.

05 · The strategyDon't deny it, unsettle it

Here is the genuinely important shift, the one worth slowing down for. The industry did not, on the whole, stand up and declare that cigarettes were safe. That would have been a losing fight, and an expensive one, because proving a product harmless against a rising tide of evidence is close to impossible. What it did instead was quieter: it worked to keep the question open. It funded studies that offered other explanations, it amplified the honest caveats that exist in any young science, and it repeated, patiently, that the matter was not settled. You do not have to win a debate to benefit from it looking like a debate. Every year the science stayed “controversial” was another year of sales, and another year without regulation.

06 · Doubt is our productThe quiet part, written down

For years this was an inference from behaviour. Then the documents surfaced. An internal memo, generally known as the “Smoking and Health Proposal” and attributed to Brown & Williamson, dated 1969, states the strategy with a candour that is almost startling: “Doubt is our product since it is the best means of competing with the ‘body of fact’ that exists in the mind of the general public.” The line goes on to explain that doubt is also the best way to establish a controversy in the first place. It is not a smoking gun so much as a strategy memo, laying out in plain terms that the product being managed was not tobacco. It was public uncertainty.

07 · The legacyA tactic that outlived the cigarette

The government did, eventually, say it plainly. On 11 January 1964, US Surgeon General Luther Terry released a report concluding that cigarette smoking causes lung cancer in men and is a serious hazard to health. Warning labels and decades of policy followed. But by then the more durable invention was already loose in the world. In their 2010 book Merchants of Doubt, historians Naomi Oreskes and Erik Conway trace how a small group of figures took the tobacco template, the funded contrarian study, the demand for impossible certainty, the insistence that the science was not settled, and reused it against other findings: acid rain, the hole in the ozone layer, and later climate change. The tactic worked precisely because it hides where it is hardest to see, inside the real, honest uncertainty that all science carries. So the answer to why doctors once recommended cigarettes is really two answers. For a while, it sold cigarettes. And when it stopped selling cigarettes, the industry discovered something more valuable than any endorsement: that you can defend almost anything, for a very long time, simply by keeping the question open.